NATCOPHARM.BONATCOPHARM.BOBSE
Loading
Net Income ScalingExpanding
Percentile Rank100
3Y CAGR+123.0%
5Y CAGR+32.5%
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

3Y CAGR
+123.0%/yr
vs -29.7%/yr prior
5Y CAGR
+32.5%/yr
Recent acceleration
Acceleration
+152.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.1x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$18.85B+35.8%
2024$13.88B+94.1%
2023$7.15B+320.8%
2022$1.70B-61.4%
2021$4.41B-4.3%
2020$4.61B-28.5%
2019$6.44B-7.4%
2018$6.96B+43.3%
2017$4.86B+209.4%
2016$1.57B-